-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On June 9th, Baiyang Pharmaceutical issued an initial public offering of shares and listed on the Growth Enterprise Market.
The initial inquiry and promotion announcement.
The number of shares to be publicly issued is 52.
6 million shares, accounting for 10.
02% of the total number of shares after the issuance.
All are public offerings For new shares, the issuer’s shareholders do not publicly sell their shares
.
After the public offering, the company's total share capital was 525.
The announcement shows that the initial strategic placement of this issuance is 7.
89 million shares, accounting for 15% of the issuance
Before the kick-back mechanism was launched, the initial offline issuance was 35.
768 million shares, accounting for 80% of the initial issuance after deducting the initial strategic allotment; the online initial issuance was 8.
The preliminary inquiry time for this issuance is 9:30-15:00 on June 15, 2021 (T-3)
.
During the above period, eligible offline investors can fill in and submit the purchase price and the quantity to be purchased through the electronic platform of the Shenzhen Stock Exchange
